Novo Nordisk Cash on Hand 2010-2024 | NVO

Novo Nordisk cash on hand for the quarter ending September 30, 2024 was $11.436B, a 54.5% increase year-over-year.

  • Novo Nordisk cash on hand for 2023 was $4.73B, a 27% increase from 2022.
  • Novo Nordisk cash on hand for 2022 was $3.724B, a 22.08% increase from 2021.
  • Novo Nordisk cash on hand for 2021 was $3.051B, a 56.1% increase from 2020.

Novo Nordisk Cash on Hand 2010-2024 | NVO

  • Novo Nordisk cash on hand for 2023 was $4.73B, a 27% increase from 2022.
  • Novo Nordisk cash on hand for 2022 was $3.724B, a 22.08% increase from 2021.
  • Novo Nordisk cash on hand for 2021 was $3.051B, a 56.1% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B